Rheumatology 2002; 41: 1021-1024
© 2002 British Society for Rheumatology
Original papers |
A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands
Department of Rheumatology, Dudley Group of Hospitals NHS Trust, The Guest Hospital, Tipton Road, Dudley, West Midlands DY1 4SE
1 Department of Rheumatology, University Hospital Birmingham NHS Trust, Selly Oak Hospital, Raddlebarn Road, Selly Oak, Birmingham B29 6JD,
2 Department of Rheumatology, The Medical School, University of Birmingham, Edgbaston, Birmingham B9 5SS,
3 The Highfield Rheumatology Unit, Worcestershire Acute Hospitals NHS Trust, Newtown Road, Worcester WR5 1JG and
4 Department of Rheumatology, City Hospital NHS Trust, Dudley Road, Birmingham B18 7QH, UK
Background. Audit is an important tool in clinical governance. Combining resources from across a region may facilitate data collection and allow variation in practice between individual units to be analysed. This audit is the first such regional audit to be carried out in rheumatology in the West Midlands and the organization and value of regional audit is discussed. This audit assessed the prevention and management of corticosteroid-induced osteoporosis (CIOP).
Methods. Adult patients attending rheumatology follow-up clinics in 10 units, during a 2-week period were assessed using the 1998 National Osteoporosis Society (NOS) guidance on the prevention and management of CIOP. The audit standard adopted was that 80% of eligible patients should be on appropriate therapy.
Results. Data was collected on 1766 (95.2%) of 1855 patients during the audit period. Two hundred and thirty-five (13.3%) were currently being prescribed or about to commence 
7.5 mg daily of oral prednisolone for 6 months. Dual X-ray absorptiometry scans were performed in 102 patients (43.4%). Of these, 53 (52%) had a T score of –1.5 or below at the hip or spine. Of the 235 patients, 202 (86%) were receiving osteoporosis treatment. One hundred and forty-eight patients (63%) were receiving appropriate osteoporosis medication according to the NOS 1998 guidelines and 87 (37%) were inappropriately treated. Of these, 71 (81.6%) were under-treated and 16 (18.4%) were over-treated.
Conclusions. Overall, the Region failed to meet the audit standard. The audit highlighted a number of differences and potential problems in the West Midlands with regard to CIOP which are currently being addressed by individual units and the West Midlands Rheumatology Services and Training Committee (WMRSTC). The Committee plan to re-audit in 2 yr.
KEY WORDS: Regional audit, Corticosteroid-induced osteoporosis, Rheumatology, Clinical governance.
Correspondence to: I. F. Rowe, Chairman, West Midlands Rheuma tology Services and Training Committee, The Highfield Rheumatology Unit, Worcestershire Acute Hospitals NHS Trust, Newtown Road, Worcester, WR5 1 JG, UK.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Wall and K. Walker-Bone Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology QJM, April 1, 2008; 101(4): 317 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Bubbear and R. W. Keen New guidelines for corticosteroid-induced osteoporosis Rheumatology, May 1, 2004; 43(5): 676 - 677. [Full Text] [PDF]
|
|
|
|
|
|
S. Miah, R. Taylor, G. McKellar, and J. Hunter Corticosteroid-induced osteoporosis Rheumatology, September 1, 2003; 42(9): 1118 - 1120. [Full Text] [PDF]
|
|